PDB155 - Six Years Of Incretin-Based Agents in Diabetes 2nd Type Treatment in the Czech Republic: The Utilization And Expenditure

Autor: Fuksa, L., Vytrisalova, M.
Zdroj: In Value in Health November 2014 17(7):A359-A359
Databáze: ScienceDirect
Externí odkaz: